10.6084/m9.figshare.c.3641030_D3.v1
Ian Krop
Ian
Krop
Shanu Modi
Shanu
Modi
Patricia LoRusso
Patricia
LoRusso
Mark Pegram
Mark
Pegram
Ellie Guardino
Ellie
Guardino
Betsy Althaus
Betsy
Althaus
Dan Lu
Dan
Lu
Alexander Strasak
Alexander
Strasak
Anthony Elias
Anthony
Elias
Additional file 3: Table S2. of Phase 1b/2a study of trastuzumab emtansine (T-DM1), paclitaxel, and pertuzumab in HER2-positive metastatic breast cancer
Springer Nature
2016
Additional
pertuzumab
HER 2-positive metastatic breast cancer All-grade AEs
PDF 72 kb
Phase
2.
phase 1 b
trastuzumab emtansine
paclitaxel
T-DM
patient population
2016-03-15 05:00:00
Journal contribution
https://springernature.figshare.com/articles/journal_contribution/Additional_file_3_Table_S2_of_Phase_1b_2a_study_of_trastuzumab_emtansine_T-DM1_paclitaxel_and_pertuzumab_in_HER2-positive_metastatic_breast_cancer/4457531
All-grade AEs (occurring in ≥20 %) or grade ≥3 AEs (occurring in >3 %) of the total patient population in phase 1b. (PDF 72 kb)